In an open-label study from Australian researchers presented here at the Ninth International Conference on Bipolar Disorder (ICBD), patients diagnosed with bipolar disorder and given 2000 mg of NAC in addition to their "treatment as usual" showed significantly lower symptom severity scores and increased functioning and quality-of-life scores.
Adjunctive N-Acetyl Cysteine Effective for Bipolar Depression
Комментариев нет:
Отправить комментарий